End-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants
Akronyymi
REBONE
Rahoitetun hankkeen kuvaus
The musculoskeletal system is extremely vulnerable to ageing and traumatic events, and common clinical conditions often exert a high burden on the clinical system. For patients requiring bone-substitute implants to treat critical-size bone defects, new solutions are required for meeting important unmet needs: personalised solutions for better clinical outcomes; improvements in materials to ensure higher mechanical reliability without compromising bioactive and bioresorbable properties; optimised manufacturing technologies for materials and products of high reliability and quality.
REBONE is a four-year doctoral network that aims to innovatively train a new generation of researchers to develop a multidisciplinary optimisation process to provide technologies for 3D-printed personalised bone replacement implants based on bioactive ceramics. The ultimate scientific goal is to construct a platform of computational tools that will enable clinical experts to produce customized bone graft substitutes for the treatment of critical-size bone defects. This innovation will ensure that an ideal treatment solution is found on a patient-specific basis in terms of: i) mechanical and mechano-biological performance, ii) surgical implantability, and iii) manufacturing process reliability.
Furthermore REBONE will develop state-of-the-art in silico models based on advanced computational methods and advanced characterisation and validation techniques to obtain personalised implants with a surgical planning visualization system in mixed reality with the following characteristics: i) tailored and reliable mechanical and physical properties; ii) best osteointegration capability; iii) targeted mechanical, physical and mechano-biological functions with patient-specific constraints taking into account the load-bearing anatomical location. Four selected clinical cases will be used as demonstrators of the optimization design and manufacturing process.
Näytä enemmänAloitusvuosi
2024
Päättymisvuosi
2027
Myönnetty rahoitus
Participant
MEDAPP SPOLKA AKCYJNA (PL)
226 512 €
Participant
ZNANOST NA CESTI, ZAVOD ZA PROMOCIJO ZNANOSTI, LJUBLJANA (SI)
Participant
CERHUM (BE)
Participant
Allgemeine Unfallversicherungsanstalt (AT)
Participant
LITHOZ GMBH (AT)
270 331.2 €
Participant
EU CORE CONSULTING SRL (IT)
Participant
LUDWIG BOLTZMANN GESELLSCHAFT OSTERREICHISCHE VEREINIGUNG ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG (AT)
270 331.2 €
Participant
UNIVERSITE PARIS XII VAL DE MARNE (FR)
Participant
FACULTY OF TECHNOLOGY AND METALLURGY UNIVERSITY OF BELGRADE (RS)
210 844.8 €
Participant
PARIS-LODRON-UNIVERSITAT SALZBURG (AT)
270 331.2 €
Participant
POLITECNICO DI MILANO (IT)
482 842.2 €
Coordinator
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO (IT)
259 437.6 €
Participant
UNIVERSITE DE LIEGE (BE)
262 620 €
Participant
POLITECNICO DI TORINO (IT)
259 437.6 €
Participant
Myönnetty summa
2 512 688 €
Rahoittaja
Euroopan unioni
Rahoitusmuoto
HORIZON TMA MSCA Doctoral Networks
Puiteohjelma
Horizon Europe (HORIZON)
Haku
Ohjelman osa
Marie Skłodowska-Curie Actions (MSCA) (11677Aihe
MSCA Doctoral Networks 2022 (HORIZON-MSCA-2022-DN-01-01Haun tunniste
HORIZON-MSCA-2022-DN-01 Muut tiedot
Rahoituspäätöksen numero
101119884